G-Quadruplexes in c-MYC Promoter as Targets for Cancer Therapy

Area of Science:

• Oncology
• Molecular Biology
• Drug Discovery

Background:

• Cancer poses a significant societal challenge, with conventional chemotherapies often exhibiting poor selectivity and severe side effects.
• The c-MYC oncogene, crucial for cell growth and division, is frequently dysregulated in cancer.
• Directly targeting the c-MYC protein has proven difficult due to its lack of a defined binding site.

Purpose of the Study:

• To review advancements in targeting G-quadruplex structures within the c-MYC promoter as a novel anticancer strategy.
• To highlight the potential of G-quadruplex-targeting agents for improved cancer treatment.

Main Methods:

• Overview of research on G-quadruplex secondary DNA structures.
• Analysis of strategies for modulating G-quadruplex formation in the c-MYC promoter region.
• Review of drug discovery efforts targeting these structures.

Main Results:

• G-quadruplexes in the c-MYC promoter can serve as a target to downregulate oncogene transcription.
• Significant progress has been made in identifying and developing small molecules that interact with these structures.
• This approach offers a promising alternative to conventional cancer therapies.

Conclusions:

• Targeting c-MYC G-quadruplexes represents a viable and innovative strategy for anticancer drug development.
• Further research in this area holds potential for creating more selective and effective cancer treatments.
• The development of G-quadruplex-binding agents could overcome limitations associated with traditional chemotherapeutics.